Chiu T, Burd A. “Xenograft” dressing in the treatment ofburns. Clin Dermatol. 2005; 23(4): 419-23. doi: 10.1016/j.
clindermatol.2004.07.027.
2. Peden M, McGee K, Sharma G. The Injury Chart Book: A Graphical Overview of the Global Burden of Injuries. Geneva:
World Health Organization; 2002.
3. Townsend CM, Sabiston DC, Townsend CM. Sabiston Textbook of Surgery Board Review. WB Saunders; 2004.
4. Jessop ZM, Al-Himdani S, Clement M, Whitaker IS. The challenge for reconstructive surgeons in the twenty-first
century: manufacturing tissue-engineered solutions. Front Surg. 2015; 2: 52. doi: 10.3389/fsurg.2015.00052.
5. Boucard N, Viton C, Agay D, Mari E, Roger T, Chancerelle Y, et al. The use of physical hydrogels of chitosan for skin
regeneration following third-degree burns. Biomaterials. 2007;28(24): 3478-88. doi: 10.1016/j.biomaterials.2007.04.021.
6. Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials. Clin Dermatol. 2005; 23(4): 403-12. doi:
10.1016/j.clindermatol.2004.07.023.
7. Cho YW, Cho YN, Chung SH, Yoo G, Ko SW. Water-soluble chitin as a wound healing accelerator. Biomaterials. 1999;
20(22): 2139-45. doi: 10.1016/s0142-9612(99)00116-7.
8. Iqbal T, Saaiq M. The burnt child: an epidemiological profile and outcome. J Coll Physicians Surg Pak. 2011; 21(11): 691-4.
9. Olaitan PB, Olaitan JO. Burns and scalds--epidemiology and prevention in a developing country. Niger J Med. 2005; 14(1):9-16. doi: 10.4314/njm.v14i1.37128.
10. Wiechman SA, Ptacek JT, Patterson DR, Gibran NS, Engrav LE,Heimbach DM. Rates, trends, and severity of depression after burn injuries. J Burn Care Rehabil. 2001; 22(6): 417-24. doi:10.1097/00004630-200111000-00012.
11. Summer GJ, Puntillo KA, Miaskowski C, Green PG, Levine JD.Burn injury pain: the continuing challenge. J Pain. 2007; 8(7):533-48. doi: 10.1016/j.jpain.2007.02.426.
12. Fauerbach JA, Lezotte D, Hills RA, Cromes GF, Kowalske K,de Lateur BJ, et al. Burden of burn: a norm-based inquiry into the influence of burn size and distress on recovery of physical and psychosocial function. J Burn Care Rehabil. 2005; 26(1):21-32. doi: 10.1097/01.bcr.0000150216.87940.ac.
13. Madianos MG, Papaghelis M, Ioannovich J, Dafni R. Psychiatric disorders in burn patients: a follow-up study. Psychother Psychosom. 2001; 70(1): 30-7. doi: 10.1159/000056222.
14. Difede J, Ptacek JT, Roberts J, Barocas D, Rives W, Apfeldorf W, et al. Acute stress disorder after burn injury: a predictor of posttraumatic stress disorder? Psychosom Med. 2002; 64(5):826-34.doi:10.1097/01.psy.0000024237.11538.08.
15. Kang YO, Jung JY, Cho D, Kwon OH, Cheon JY, Park WH. Antimicrobial silver chloride nanoparticles stabilized with
chitosan oligomer for the healing of burns. Materials (Basel)2016; 9(4): 215. doi: 10.3390/ma9040215.
16. Jin Y, Ling PX, He YL, Zhang TM. Effects of chitosan and heparin on early extension of burns. Burns. 2007; 33(8): 1027-31. doi: 10.1016/j.burns.2006.12.002.
17. Liu LN, Li XY, Zhao CY, Guan B, Wu XC, Zhang T, et al.Efficacy and safety of chitosan wound dressing for deep
second-degree burn: a prospective, single-blind, randomized controlled trial. Chinese J Tissue Eng Res. 2017; 21(14): 2222-6. doi: 10.3969/j.issn.2095-4344.2017.14.015.
18. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement
for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and
explanations. Ann Intern Med. 2015; 162(11): 777-84. doi:10.7326/m14-2385.
19. Murakami K, Aoki H, Nakamura S, Nakamura S, Takikawa M, Hanzawa M, et al. Hydrogel blends of chitin/chitosan,
fucoidan and alginate as healing-impaired wound dressings. Biomaterials. 2010; 31(1): 83-90. doi: 10.1016/j.biomaterials.2009.09.031.
20. Aoyagi S, Onishi H, Machida Y. Novel chitosan wound dressing loaded with minocycline for the treatment of severe
burn wounds. Int J Pharm. 2007; 330(1-2): 138-45. doi:10.1016/J.ijpharm.2006.09.016.
21. Oryan A, Sahvieh S. Effectiveness of chitosan scaffold in skin, bone and cartilage healing. Int J Biol Macromol. 2017; 104(PtA): 1003-11. doi: 10.1016/j.ijbiomac.2017.06.124.